描述肝细胞癌干细胞标志物及其对NK细胞基础免疫疗法的相应敏感性
Jason Chiang1,2, Po-Chun Chen3, Janet Pham1
1Department of Radiology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, United States.
Frontiers in immunology
|November 13, 2023
概括
差差分化的肝细胞癌 (HCC) 呈现癌症干细胞 (CSC) 标记物,增加对自然杀手细胞 (NK) 免疫疗法的敏感性. 超充电的NK细胞对两种HCC类型都表现有前途.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 免疫学 免疫学 免疫学
- 癌症干细胞是癌症干细胞.
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 组织病理学差异化影响HCC治疗结果,差异化HCC的预后更差.
- 癌症干细胞 (CSC) 档案与HCC进展和治疗耐药性有关.
研究的目的:
- 在实验室中描述癌症干细胞 (CSC) 形状,分化良好和差异化不良的HCC.
- 评估不同HCC等级对NK细胞介导的细胞毒性的敏感性.
主要方法:
- 流细胞计用于分析HC细胞上的表面标记物 (MHC类I,CD54,CD44).
- 细胞毒性测定使用初级NK细胞,IL-2刺激的NK细胞和超载NK (sNK) 细胞进行.
- 实时定量成像 (eSight) 用于分析NK细胞效应器功能.
主要成果:
- 差差分化的HCC显示CSC表面标记模式 (低MHC类I/CD54,高CD44).
- 差异化HCC在所有测试的NK细胞类型中更容易受到NK细胞介导的杀死.
- 超电荷的NK细胞表现出强烈的细胞毒性,对差异化和差异化HCC.
结论:
- 差异化HCC表现出CSC特征,使它们易受NK细胞基础免疫治疗的影响.
- 基于NK细胞的疗法,特别是sNK细胞,为HCC提供了一个有前途的新辅助或辅助治疗策略.
- sNK细胞表现出增强的细胞毒性和对T细胞激活HCC的潜力.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
928
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
928
01:27Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533